These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34358081)

  • 1. ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential.
    Deb S; Reeves AA; Hopefl R; Bejusca R
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions.
    Deb S; Reeves AA
    J Pharm Pharm Sci; 2021; 24():277-291. PubMed ID: 34107241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The journey of remdesivir: from Ebola to COVID-19.
    Pardo J; Shukla AM; Chamarthi G; Gupte A
    Drugs Context; 2020; 9():. PubMed ID: 32547625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance.
    Yan D; Ra OH; Yan B
    Anim Dis; 2021; 1(1):15. PubMed ID: 34778881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir.
    Bakheit AH; Darwish H; Darwish IA; Al-Ghusn AI
    Profiles Drug Subst Excip Relat Methodol; 2023; 48():71-108. PubMed ID: 37061276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside.
    Tao S; Zandi K; Bassit L; Ong YT; Verma K; Liu P; Downs-Bowen JA; McBrayer T; LeCher JC; Kohler JJ; Tedbury PR; Kim B; Amblard F; Sarafianos SG; Schinazi RF
    Curr Res Pharmacol Drug Discov; 2021; 2():100045. PubMed ID: 34870151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
    Nguyen HL; Thai NQ; Truong DT; Li MS
    J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro.
    Brunotte L; Zheng S; Mecate-Zambrano A; Tang J; Ludwig S; Rescher U; Schloer S
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19.
    Tamura R; Irie K; Nakagawa A; Muroi H; Eto M; Ikesue H; Muroi N; Fukushima S; Tomii K; Hashida T
    CPT Pharmacometrics Syst Pharmacol; 2023 Apr; 12(4):513-521. PubMed ID: 36798006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
    Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK
    Molecules; 2020 May; 25(10):. PubMed ID: 32429580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An
    Xie J; Wang Z
    Acta Pharm Sin B; 2021 Jun; 11(6):1607-1616. PubMed ID: 34221871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoramidate Prodrugs Continue to Deliver, The Journey of Remdesivir (GS-5734) from RSV to SARS-CoV-2.
    Mackman RL
    ACS Med Chem Lett; 2022 Mar; 13(3):338-347. PubMed ID: 35291757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population pharmacokinetic model of remdesivir and its major metabolites based on published mean values from healthy subjects.
    Abouellil A; Bilal M; Taubert M; Fuhr U
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jan; 396(1):73-82. PubMed ID: 36123499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Zhang L; Zhou R
    J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remdesivir for the Treatment of COVID-19: A Narrative Review.
    Godwin PO; Polsonetti B; Caron MF; Oppelt TF
    Infect Dis Ther; 2024 Jan; 13(1):1-19. PubMed ID: 38193988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    de Wit E; Feldmann F; Cronin J; Jordan R; Okumura A; Thomas T; Scott D; Cihlar T; Feldmann H
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6771-6776. PubMed ID: 32054787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.